NASDAQ:ORPN - Bioblast Pharma Ltd.
$1.17
 $0.07
+6.27%
1:50PM EDT
2019-02-15
Bio Blast Pharma Ltd. (BioBlast), incorporated on January 22, 2012, is a development-stage biopharmaceutical company. The Company is focused on the identification, licensing, acquisition, development and commercialization of drugs for rare and ultra-rare genetic and metabolic diseases. It focuses on therapeutic platforms that offer solutions for several diseases that share a common pathophysiological mechanism, which are the functional changes that accompany a particular syndrome or disease. It also focuses on diseases with severe and debilitating manifestations. The Company has several drug candidates in clinical or preclinical development targeting neuromuscular/central nervous system (CNS) and mitochondrial diseases. Its drug candidates include Trehalose IV Solution, BB-FA (Bioblast-Friedreich's ataxia) and BBrm-02. The Company's product candidate platforms include Protein Stabilizing Platform, Read-through Platform and Mitochondrial Protein Replacement Platform.Trehalose IV SolutionTrehalose is a mutant protein stabilizer and autophagy enhancer. Trehalose is used for the treatment of PolyA/PolyQ diseases, including oculopharyngeal muscular dystrophy (OPMD), and spinocerebellar ataxia type 3 (SCA3; Machado Joseph disease), and taupathies. Patients enrolled in the Company's trials of trehalose IV solution for OPMD, known as open label HOPEMD clinical trial, and for SCA3 trial, may suffer side effects associated with the use of trehalose IV solution. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  ORPN     avg for
industry  
  avg for
sector  
42 stocks weight:  11. 96   0. 00   0. 00  
42 stocks rank:  3. 88 K 1. 86 K 1. 09 K
# analyst opinions:  1. 00   14. 92   14. 43  

quick ratio:  11. 83   5. 37   1. 81  
current ratio:  11. 83   5. 69   2. 19  

target price low:  0. 90   88. 97   117. 82  
target price avg:  0. 90   115. 19   141. 96  
target price high:  0. 90   143. 40   163. 16  
1-yr high:  3. 07   124. 30   142. 77  
last close:  1. 10   101. 85   127. 84  
50-day avg:  1. 05   98. 27   122. 46  
200-day avg:  1. 45   99. 72   122. 70  
1-yr low:  0. 77   78. 19   100. 16  
volume:  3. 91 K 2. 38 M 4. 64 M
50-day avg volume:  23. 36 K 3. 31 M 4. 94 M
200-day avg volume:  107. 10 K 3. 23 M 4. 28 M

1-day return:  -4. 35 % 0. 22 % 0. 48 %
this week return:  -4. 35 % 1. 77 % 2. 01 %
12-wk return:  -14. 06 % 6. 56 % 3. 33 %
52-wk return:  -59. 93 % -2. 23 % 14. 35 %

enterprise value (EV):  2. 19 M 55. 17 B 104. 51 B
market cap:  3. 69 M 49. 01 B 96. 46 B
EBITDA:  -3. 29 M 4. 82 B 7. 18 B
enterprise multiple (EV/EBITDA):  -0. 67   -91. 79   2. 29  
total debt:  0. 00   13. 73 B 16. 57 B
net income (common):  -3. 33 M 2. 37 B 3. 58 B

shares outstanding:  3. 36 M 607. 99 M 1. 22 B
shares:  1. 58 M 605. 53 M 1. 15 B
shares short:  138. 89 K 11. 62 M 12. 55 M
shares short prior month:  170. 53 K 11. 95 M 13. 44 M
short ratio:  6. 10   4. 82   3. 10  
total cash/share:  0. 50   12. 02   11. 46  
total cash:  1. 67 M 7. 41 B 7. 37 B

book value:  0. 46   14. 43   28. 26  
price/book:  2. 37   -1. 57   -2. 97  
gross profits:  -2. 46 M 8. 28 B 18. 09 B
operating margins:  0. 00 % -458. 01 % -642. 83 %
EBITDA margins:  0. 00 % 13. 81 % 22. 47 %
profit margins:  0. 00 % 6. 57 % 9. 92 %
gross margins:  0. 00 % 49. 33 % 54. 53 %

1-yr max volatility:  30. 25 % --- ---
1-yr mean volatility:  -0. 20 % 0. 01 % 0. 06 %

1-yr EPS:  -0. 99   3. 03   4. 09  
forward EPS:  -0. 73   4. 33   6. 99  
P/E:  -1. 11   6. 11   26. 91  
forward P/E:  -1. 58   8. 38   10. 48  
PE/G:  0. 04   0. 37   5. 61  
growth:  -29. 82 % 683. 72 % 104. 79 %
earnings high:  -0. 00   1. 27   1. 66  
earnings avg:  -0. 00   1. 01   1. 53  
earnings low:  -0. 00   0. 76   1. 40  
revenue high:  -0. 00   2. 86 B 11. 19 B
revenue avg:  -0. 00   2. 78 B 10. 84 B
revenue low:  -0. 00   2. 67 B 10. 64 B
return on assets:  -56. 16 % -3. 27 % 3. 81 %
return on equity:  -106. 14 % 107. 48 % 27. 82 %

beta (1yr vs S&P500):  0. 38   1. 21   0. 93  
sharpe (1yr):  -0. 51   0. 06   0. 98  

held % insiders:  36. 85 % 6. 46 % 3. 21 %
held % institutions:  18. 97 % 79. 10 % 70. 01 %

Research more with google or yahoo!
the data below are updated and published after 9pm EDT each trading day

2019-02-14 : ORPN
.    + 0.054 =         0.054 :: INITIAL WEIGHT
.  + 435.403 =       435.456 :: inverse volume-to-price addition
.  + 175.686 =       611.143 :: spline projection addition
.  - 212.633 =        398.51 :: poor performance penalty
.    x 0.633 =       252.188 :: one-year gains+dividend factor
.    x 6.696 =      1688.759 :: 13 weeks' performance factor
.    x 1.492 =      2520.454 :: industry recommendation factor
.    x 0.994 =      2506.299 :: return on assets factor
.    x 0.989 =      2479.696 :: return on equity factor
.    x 2.078 =      5153.579 :: current ratio factor
.    x 1.045 =      5386.194 :: quick ratio factor
.    x 1.079 =      5810.939 :: short ratio factor
.    x 2.024 =     11759.637 :: price-to-book factor
.    x 1.067 =     12542.541 :: 5-day avg > 50-day avg
.     x 2.17 =      27221.87 :: P/E weight
.    x 2.209 =     60131.997 :: PE/G factor
.    x 1.638 =     98472.575 :: beta factor
.    x 0.506 =     49831.097 :: sharpe factor
.    x 0.957 =     47706.292 :: target low factor
.    x 0.924 =     44100.761 :: target mean factor
.    x 0.957 =     42220.298 :: target high factor
.    x 1.066 =     44990.491 :: industry 12-weeks return
.    x 0.893 =     40179.951 :: "drift" penalty 2 days ago
.     x 0.99 =     39798.175 :: "drift" penalty 3 days ago
.     x 0.99 =     39393.959 :: overall "drift" factor
.    x 0.697 =     27476.463 :: largest single-day jump factor
.    x 0.062 =      1708.735 :: low price factor
.      x 1.0 =       1708.85 :: factor hist industry gain for week 06
.   cubeRoot =        11.956 :: reduced for readability
.                     11.956 :: FINAL WEIGHT for NASDAQ:ORPN


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org